Molecular basis of defective CD8 T cells during chronic viral infection

慢性病毒感染期间缺陷型 CD8 T 细胞的分子基础

基本信息

  • 批准号:
    7835681
  • 负责人:
  • 金额:
    $ 23.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-08 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): CD8 T cells play an important role in the clearance of many viral infections and in providing protective immunity against re-infection. In assessing the effectiveness of the CD8 T cell response, most studies have focused on correlating the magnitudes of the response with the level of protection it provides. However, recent studies have shown that effective control of viral infection is dependent on not only the quantity but also the quality of antigen-specific CD8 T cells. Using infection of mice with lymphocytic choriomeningitis virus (LCMV) as a model, we have discovered that memory CD8 T cells generated in the absence of CD4 T cell help are of poor quality. These "unhelped" memory CD8 T cells have a decreased ability to persist, produce low levels of effector cytokines following restimulation, and most significantly, do not provide adequate protection against secondary challenge. This loss of functionality in CD8 T cells is also observed during chronic LCMV infection and is thought to contribute to the failure of the host to clear the infection. Our recent studies have been focused on elucidating the mechanisms behind why "unhelped" CD8 T cells are unable to function properly. We have shown that defects in "unhelped" memory CD8 T cells are not due to aberrations in the TCR repertoire nor to impairment in functional avidity maturation. Instead, our results show that the defect lies downstream of TCR signaling and is due to a failure of these cells to undergo specific epigenetic modifications at several loci critical for effector functions. We will test the hypothesis that a failure of CD8 T cells to undergo requisite epigenetic modifications contributes to their inability to function properly during chronic LCMV infection. More specifically, in Aim 1 we will determine if differences in epigenetic remodeling contribute to the inability of antigen-specific CD8 T cells to function properly during chronic infection. In Aim 2, we will examine if the defective CD8 T cells that arise during chronic infection can be reprogrammed through epigenetic modification to gain full functionality. The results of these studies may help us develop new strategies that will improve the functionality of CD8 T cells and thus enhance immune control of viral infection. PUBLIC HEALTH RELEVANCE Clearance of many viral infections is critically dependent on the function of CD8 T cells. Recent results have shown that CD8 T cells become functionally defective when CD4 T cell help is absent. This loss of functionality in CD8 T cells is also observed during chronic viral infection and is thought to contribute to the failure of the host to clear the infection. In this study, we aim to understand why CD8 T cells become defective during chronic viral infection and in the absence of CD4 T cells help. In doing so, we hope to develop new strategies that will enhance the functionality of CD8 T cells and thus immune control of viral infection.
DESCRIPTION (provided by applicant): CD8 T cells play an important role in the clearance of many viral infections and in providing protective immunity against re-infection. In assessing the effectiveness of the CD8 T cell response, most studies have focused on correlating the magnitudes of the response with the level of protection it provides. However, recent studies have shown that effective control of viral infection is dependent on not only the quantity but also the quality of antigen-specific CD8 T cells. Using infection of mice with lymphocytic choriomeningitis virus (LCMV) as a model, we have discovered that memory CD8 T cells generated in the absence of CD4 T cell help are of poor quality. These "unhelped" memory CD8 T cells have a decreased ability to persist, produce low levels of effector cytokines following restimulation, and most significantly, do not provide adequate protection against secondary challenge. This loss of functionality in CD8 T cells is also observed during chronic LCMV infection and is thought to contribute to the failure of the host to clear the infection. Our recent studies have been focused on elucidating the mechanisms behind why "unhelped" CD8 T cells are unable to function properly. We have shown that defects in "unhelped" memory CD8 T cells are not due to aberrations in the TCR repertoire nor to impairment in functional avidity maturation. Instead, our results show that the defect lies downstream of TCR signaling and is due to a failure of these cells to undergo specific epigenetic modifications at several loci critical for effector functions. We will test the hypothesis that a failure of CD8 T cells to undergo requisite epigenetic modifications contributes to their inability to function properly during chronic LCMV infection. More specifically, in Aim 1 we will determine if differences in epigenetic remodeling contribute to the inability of antigen-specific CD8 T cells to function properly during chronic infection. In Aim 2, we will examine if the defective CD8 T cells that arise during chronic infection can be reprogrammed through epigenetic modification to gain full functionality. The results of these studies may help us develop new strategies that will improve the functionality of CD8 T cells and thus enhance immune control of viral infection. PUBLIC HEALTH RELEVANCE Clearance of many viral infections is critically dependent on the function of CD8 T cells. Recent results have shown that CD8 T cells become functionally defective when CD4 T cell help is absent. This loss of functionality in CD8 T cells is also observed during chronic viral infection and is thought to contribute to the failure of the host to clear the infection. In this study, we aim to understand why CD8 T cells become defective during chronic viral infection and in the absence of CD4 T cells help. In doing so, we hope to develop new strategies that will enhance the functionality of CD8 T cells and thus immune control of viral infection.

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptome Signatures Reveal Rapid Induction of Immune-Responsive Genes in Human Memory CD8(+) T Cells.
转录组特征揭示了人类记忆 CD8( ) T 细胞中免疫反应基因的快速诱导。
  • DOI:
    10.1038/srep27005
  • 发表时间:
    2016-05-31
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Yang C;Khanniche A;DiSpirito JR;Ji P;Wang S;Wang Y;Shen H
  • 通讯作者:
    Shen H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hao Shen其他文献

Hao Shen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hao Shen', 18)}}的其他基金

Regenerative therapy for lung infection by S. pneumoniae
肺炎链球菌肺部感染的再生治疗
  • 批准号:
    9388099
  • 财政年份:
    2017
  • 资助金额:
    $ 23.63万
  • 项目类别:
Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells
通过对耗尽的 CD8 T 细胞进行表观遗传重编程来治疗慢性病毒感染
  • 批准号:
    9768950
  • 财政年份:
    2017
  • 资助金额:
    $ 23.63万
  • 项目类别:
Microbiology Core
微生物学核心
  • 批准号:
    8089288
  • 财政年份:
    2010
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response
细菌共感染对呼吸道病毒特异性 T 细胞反应的影响
  • 批准号:
    8089283
  • 财政年份:
    2010
  • 资助金额:
    $ 23.63万
  • 项目类别:
Molecular basis of defective CD8 T cells during chronic viral infection
慢性病毒感染期间缺陷型 CD8 T 细胞的分子基础
  • 批准号:
    7522985
  • 财政年份:
    2009
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response
细菌共感染对呼吸道病毒特异性 T 细胞反应的影响
  • 批准号:
    7746167
  • 财政年份:
    2009
  • 资助金额:
    $ 23.63万
  • 项目类别:
New attenuated anthrax vaccine
新型减毒炭疽疫苗
  • 批准号:
    7056575
  • 财政年份:
    2006
  • 资助金额:
    $ 23.63万
  • 项目类别:
New attenuated anthrax vaccine
新型减毒炭疽疫苗
  • 批准号:
    7267678
  • 财政年份:
    2006
  • 资助金额:
    $ 23.63万
  • 项目类别:
Modulation of T cell Responses by Ebola Glycoprotein
埃博拉糖蛋白对 T 细胞反应的调节
  • 批准号:
    6570789
  • 财政年份:
    2002
  • 资助金额:
    $ 23.63万
  • 项目类别:
Modulation of T cell Responses by Ebola Glycoprotein
埃博拉糖蛋白对 T 细胞反应的调节
  • 批准号:
    6656939
  • 财政年份:
    2002
  • 资助金额:
    $ 23.63万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了